Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지

Altered Complexin Expression in Psychiatric and Neurological Disorders: Cause or Consequence?

  • Brose, Nils (Department of Molecular Neurobiology, Max Planck Institute of Experimental Medicine)
  • Received : 2008.02.13
  • Accepted : 2008.02.15
  • Published : 2008.02.29
⟨ Previous Next ⟩

Abstract

Complexins play a critical role in the control of fast synchronous neurotransmitter release. They operate by binding to trimeric SNARE complexes consisting of the vesicle protein Synaptobrevin and the plasma membrane proteins Syntaxin and SNAP-25, which are key executors of membrane fusion reactions. SNARE complex binding by Complexins is thought to stabilize and clamp the SNARE complex in a highly fusogenic state, thereby providing a pool of readily releasable synaptic vesicles that can be released quickly and synchronously in response to an action potential and the concomitant increase in intra-synaptic $Ca^{2+}$ levels. Genetic elimination of Complexins from mammalian neurons causes a strong reduction in evoked neurotransmitter release, and altered Complexin expression levels with consequent deficits in synaptic transmission were suggested to contribute to the etiology or pathogenesis of schizophrenia, Huntington's disease, depression, bipolar disorder, Parkinson's disease, Alzheimer's disease, traumatic brain injury, Wernicke's encephalopathy, and fetal alcohol syndrome. In the present review I provide a summary of available data on the role of altered Complexin expression in brain diseases. On aggregate, the available information indicates that altered Complexin expression levels are unlikely to have a causal role in the etiology of the disorders that they have been implicated in, but that they may contribute to the corresponding symptoms.

Keywords

Acknowledgement

Supported by : Max Planck Society

References

  1. Augustin, I., Rosenmund, C., Sudhof, T.C., and Brose, N. (1999). Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature 400, 457-461 https://doi.org/10.1038/22768
  2. Barr, A.M., Hofmann, C.E., Phillips, A.G., Weinberg, J., and Honer, W.G. (2005). Prenatal ethanol exposure in rats decreases levels of complexin proteins in the frontal cortex. Alcohol Clin. Exp. Res. 29, 1915-1920 https://doi.org/10.1097/01.alc.0000187806.68957.0a
  3. Basso, M., Giraudo, S., Corpillo, D., Bergamasco, B., Lopiano, L., and Fasano, M. (2004). Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4, 3943-3952 https://doi.org/10.1002/pmic.200400848
  4. Beasley, C.L., Pennington, K., Behan, A., Wait, R., Dunn, M.J., and Cotter, D. (2006). Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6, 3414-3425 https://doi.org/10.1002/pmic.200500069
  5. Butterfield, D.A. and Boyd-Kimball, D. (2004). Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration. Int. Rev. Neurobiol. 61, 159-188 https://doi.org/10.1016/S0074-7742(04)61007-5
  6. Cha, J.H. (2007). Transcriptional signatures in Huntington's disease. Prog. Neurobiol. 83, 228-248 https://doi.org/10.1016/j.pneurobio.2007.03.004
  7. DiProspero, N.A., Chen, E.Y., Charles, V., Plomann, M., Kordower, J.H., and Tagle, D.A. (2004). Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. J. Neurocytol. 33, 517-533 https://doi.org/10.1007/s11068-004-0514-8
  8. Drabik, A., Bierczynska-Krzysik, A., Bodzon-Kulakowska, A., Suder, P., Kotlinska, J., and Silberring, J. (2007). Proteomics in neurosciences. Mass Spectrom. Rev. 26, 432-450 https://doi.org/10.1002/mas.20131
  9. Drew, C.J., Kyd, R.J., and Morton, A.J. (2007). Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normal. Hum. Mol. Genet. 16, 2288-2305 https://doi.org/10.1093/hmg/ddm181
  10. Dubois, M., Vacher, P., Roger, B., Huyghe, D., Vandewalle, B., Kerr-Conte, J., Pattou, F., Moustaid-Moussa, N., and Lang, J. (2007). Glucotoxicity inhibits late steps of insulin exocytosis. Endocrinology 148, 1605-1614 https://doi.org/10.1210/en.2006-1022
  11. Eastwood, S.L. and Harrison, P.J. (2000). Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol. Psychiatry 5, 425-432 https://doi.org/10.1038/sj.mp.4000741
  12. Eastwood, S.L. and Harrison, P.J. (2001). Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res. Bull. 55, 569-578 https://doi.org/10.1016/S0361-9230(01)00530-5
  13. Eastwood, S.L. and Harrison, P.J. (2005). Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr. Res. 73, 159-172 https://doi.org/10.1016/j.schres.2004.05.010
  14. Eastwood, S.L., Burnet, P.W., and Harrison, P.J. (2000). Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse 36, 167-177 https://doi.org/10.1002/(SICI)1098-2396(20000601)36:3<167::AID-SYN2>3.0.CO;2-D
  15. Eastwood, S.L., Cotter, D., and Harrison, P.J. (2001). Cerebellar synaptic protein expression in schizophrenia. Neuroscience 105, 219-229 https://doi.org/10.1016/S0306-4522(01)00141-5
  16. Edwardson, J.M., Wang, C.T., Gong, B., Wyttenbach, A., Bai, J., Jackson, M.B., Chapman, E.R., and Morton, A.J. (2003). Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II. J. Biol. Chem. 278, 30849-30853 https://doi.org/10.1074/jbc.M304615200
  17. Freeman, W. and Morton, A.J. (2004a). Differential messenger RNA expression of complexins in mouse brain. Brain Res. Bull. 63, 33-44 https://doi.org/10.1016/j.brainresbull.2003.12.003
  18. Freeman, W. and Morton, A.J. (2004b). Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation. Brain Res. Bull. 63, 45-55 https://doi.org/10.1016/j.brainresbull.2003.12.004
  19. Giraudo, C.G., Eng, W.S., Melia, T.J., and Rothman, J.E. (2006). A clamping mechanism involved in SNARE-dependent exocytosis. Science 313, 676-680 https://doi.org/10.1126/science.1129450
  20. Glynn, D., Bortnick, R.A., and Morton, A.J. (2003). Complexin II is essential for normal neurological function in mice. Hum. Mol. Genet. 12, 2431-2448 https://doi.org/10.1093/hmg/ddg249
  21. Glynn, D., Drew, C.J., Reim, K., Brose, N., and Morton, A.J. (2005). Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits. Hum. Mol. Genet. 14, 2369-2385 https://doi.org/10.1093/hmg/ddi239
  22. Glynn, D., Reim, K., Brose, N., and Morton, A.J. (2007a). Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD. Brain Res. Bull. 72, 108-120 https://doi.org/10.1016/j.brainresbull.2006.10.017
  23. Glynn, D., Sizemore, R.J., and Morton, A.J. (2007b). Early motor development is abnormal in complexin 1 knockout mice. Neurobiol. Dis. 25, 483-495 https://doi.org/10.1016/j.nbd.2006.10.011
  24. Harrison, P.J. and Eastwood, S.L. (1998). Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352, 1669-1673 https://doi.org/10.1016/S0140-6736(98)03341-8
  25. Hazell, A.S. and Wang, C. (2005). Downregulation of complexin I and complexin II in the medial thalamus is blocked by N-acetylcysteine in experimental Wernicke's encephalopathy. J. Neurosci. Res. 79, 200-207 https://doi.org/10.1002/jnr.20278
  26. Huntwork, S. and Littleton, J.T. (2007). A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growth. Nat. Neurosci. 10, 1235-1237 https://doi.org/10.1038/nn1980
  27. Ishizuka, T., Saisu, H., Odani, S., Kumanishi, T., and Abe, T. (1999). Distinct regional distribution in the brain of messenger RNAs for the two isoforms of synaphin associated with the docking/fusion complex. Neuroscience 88, 295-306 https://doi.org/10.1016/S0306-4522(98)00223-1
  28. Jahn, R. and Scheller, R.H. (2006). SNAREs--engines for membrane fusion. Nat. Rev. Mol. Cell. Biol. 7, 631-643 https://doi.org/10.1038/nrm2002
  29. Jockusch, W.J., Speidel, D., Sigler, A., Sorensen, J.B., Varoqueaux, F., Rhee, J.S., and Brose, N. (2007). CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins. Cell 131, 796-808 https://doi.org/10.1016/j.cell.2007.11.002
  30. Kishi, T., Ikeda, M., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Ozaki, N., and Iwata, N. (2006). No association of complexin1 and complexin2 genes with schizophrenia in a Japanese population. Schizophr. Res. 82, 185-189 https://doi.org/10.1016/j.schres.2005.12.842
  31. Knable, M.B., Barci, B.M., Webster, M.J., Meador-Woodruff, J., and Torrey, E.F. (2004). Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the stanley neuropathology consortium. Mol. Psychiatry 9, 609-620, 544 https://doi.org/10.1038/sj.mp.4001471
  32. Lee, H.J., Song, J.Y., Kim, J.W., Jin, S.Y., Hong, M.S., Park, J.K., Chung, J.H., Shibata, H., and Fukumaki, Y. (2005). Association study of polymorphisms in synaptic vesicleassociated genes, SYN2 and CPLX2, with schizophrenia. Behav. Brain Funct. 1, 15 https://doi.org/10.1186/1744-9081-1-15
  33. Lewis, D.A. and Mirnics, K. (2006). Transcriptome alterations in schizophrenia: disturbing the functional architecture of the dorsolateral prefrontal cortex. Prog. Brain Res. 158, 141-152 https://doi.org/10.1016/S0079-6123(06)58007-0
  34. McMahon, H.T., Missler, M., Li, C., and Sudhof, T.C. (1995). Complexins: cytosolic proteins that regulate SNAP receptor function. Cell 83, 111-119 https://doi.org/10.1016/0092-8674(95)90239-2
  35. Melia, T.J., Jr. (2007). Putting the clamps on membrane fusion: how complexin sets the stage for calcium-mediated exocytosis. FEBS Lett. 581, 2131-2139 https://doi.org/10.1016/j.febslet.2007.02.066
  36. Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A., and Levitt, P. (2000). Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67 https://doi.org/10.1016/S0896-6273(00)00085-4
  37. Morton, A.J. and Edwardson, J.M. (2001). Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease. J. Neurochem. 76, 166-172 https://doi.org/10.1046/j.1471-4159.2001.00059.x
  38. Morton, A.J., Faull, R.L., and Edwardson, J.M. (2001). Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease. Brain Res. Bull. 56, 111-117 https://doi.org/10.1016/S0361-9230(01)00611-6
  39. Mufson, E.J., Counts, S.E., Che, S., and Ginsberg, S.D. (2006). Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease. Prog. Brain Res. 158, 197-222 https://doi.org/10.1016/S0079-6123(06)58010-0
  40. Nakahara, T., Motomura, K., Hashimoto, K., Ueki, H., Gotoh, L., Hondo, H., Tsutsumi, T., Kuroki, T., Hirano, M., and Uchimura, H. (2000). Long-term treatment with haloperidol decreases the mRNA levels of complexin I, but not complexin II, in rat prefrontal cortex, nucleus accumbens and ventral tegmental area. Neurosci. Lett. 290, 29-32 https://doi.org/10.1016/S0304-3940(00)01312-4
  41. Novikova, S.I., He, F., Cutrufello, N.J., and Lidow, M.S. (2006). Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF- PSD-MS analysis. Neurobiol. Dis. 23, 61-76 https://doi.org/10.1016/j.nbd.2006.02.002
  42. Patel, S., Sinha, A., and Singh, M.P. (2007). Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson's disease phenotype in mouse. Neurotoxicol. Teratol. 29, 578-585 https://doi.org/10.1016/j.ntt.2007.04.002
  43. Pennington, K., Beasley, C.L., Dicker, P., Fagan, A., English, J., Pariante, C.M., Wait, R., Dunn, M.J., and Cotter, D.R. (2007). Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol. Psychiatry [Epub ahead of print]
  44. Raedler, T.J. and Wiedemann, K. (2006). CSF-studies in neuropsychiatric disorders. Neuro Endocrinol. Lett. 27, 297-305
  45. Reim, K., Mansour, M., Varoqueaux, F., McMahon, H.T., Sudhof, T.C., Brose, N., and Rosenmund, C. (2001). Complexins regulate a late step in $Ca^{2+}$-dependent neurotransmitter release. Cell 104, 71-81 https://doi.org/10.1016/S0092-8674(01)00192-1
  46. Reim, K., Wegmeyer, H., Brandstatter, J.H., Xue, M., Rosenmund, C., Dresbach, T., Hofmann, K., and Brose, N. (2005). Structurally and functionally unique complexins at retinal ribbon synapses. J. Cell Biol. 169, 669-680 https://doi.org/10.1083/jcb.200502115
  47. Rizo, J., Chen, X., and Arac, D. (2006). Unraveling the mechanisms of synaptotagmin and SNARE function in neurotransmitter release. Trends Cell Biol. 16, 339-350 https://doi.org/10.1016/j.tcb.2006.04.006
  48. Rosenmund, C., Rettig, J., and Brose, N. (2003). Molecular mechanisms of active zone function. Curr. Op. Neurobiol. 13, 509-519 https://doi.org/10.1016/j.conb.2003.09.011
  49. Salimi, K., Glantz, L.A., Hamer, R.M., German, T.T., Gilmore, J.H., and Jarskog, L.F. (2008). Regulation of Complexin 1 and Complexin 2 in the developing human prefrontal cortex. Synapse 62, 273-282 https://doi.org/10.1002/syn.20492
  50. Sawada, K., Barr, A.M., Nakamura, M., Arima, K., Young, C.E., Dwork, A.J., Falkai, P., Phillips, A.G., and Honer, W.G. (2005). Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch. Gen. Psychiatry 62, 263-272 https://doi.org/10.1001/archpsyc.62.3.263
  51. Sawada, K., Young, C.E., Barr, A.M., Longworth, K., Takahashi, S., Arango, V., Mann, J.J., Dwork, A.J., Falkai, P., Phillips, A.G., et al. (2002). Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol. Psychiatry 7, 484-492 https://doi.org/10.1038/sj.mp.4000978
  52. Schaub, J.R., Lu, X., Doneske, B., Shin, Y.K., and McNew, J.A. (2006). Hemifusion arrest by complexin is relieved by $Ca^{2+}$- synaptotagmin I. Nat. Struct. Mol. Biol. 13, 748-750 https://doi.org/10.1038/nsmb1124
  53. Schmidt, O., Schulenborg, T., Meyer, H.E., Marcus, K., and Hamacher, M. (2005). How proteomics reveals potential biomarkers in brain diseases. Exp. Rev. Proteomics 2, 901-913 https://doi.org/10.1586/14789450.2.6.901
  54. Sequeira, A. and Turecki, G. (2006). Genome wide gene expression studies in mood disorders. OMICS 10, 444-454 https://doi.org/10.1089/omi.2006.10.444
  55. Takahashi, S., Yamamoto, H., Matsuda, Z., Ogawa, M., Yagyu, K., Taniguchi, T., Miyata, T., Kaba, H., Higuchi, T., Okutani, F., et al. (1995). Identification of two highly homologous presynaptic proteins distinctly localized at the dendritic and somatic synapses. FEBS Lett. 368, 455-460 https://doi.org/10.1016/0014-5793(95)00713-J
  56. Tang, J., Maximov, A., Shin, O.H., Dai, H., Rizo, J., and Sudhof, T.C. (2006). A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis. Cell 126, 1175-1187 https://doi.org/10.1016/j.cell.2006.08.030
  57. Tannenberg, R.K., Scott, H.L., Tannenberg, A.E., and Dodd, P.R. (2006). Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4. Neurochem. Int. 49, 631-639 https://doi.org/10.1016/j.neuint.2006.05.004
  58. Varoqueaux, F., Aramuni, G., Rawson, R.L., Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Sudhof, T.C., and Brose, N. (2006). Neuroligins determine synapse maturation and function. Neuron 51, 741-754 https://doi.org/10.1016/j.neuron.2006.09.003
  59. Witzmann, F.A., Li, J., Strother, W.N., McBride, W.J., Hunter, L., Crabb, D.W., Lumeng, L., and Li, T.K. (2003). Innate differences in protein expression in the nucleus accumbens and hippocampus of inbred alcohol-preferring and -nonpreferring rats. Proteomics 3, 1335-1344 https://doi.org/10.1002/pmic.200300453
  60. Wojcik, S.M. and Brose, N. (2007). Regulation of membrane fusion in synaptic excitation-secretion coupling: speed and accuracy matter. Neuron 55, 11-24 https://doi.org/10.1016/j.neuron.2007.06.013
  61. Xue, M., Reim, K., Chen, X., Chao, H.T., Deng, H., Rizo, J., Brose, N., and Rosenmund, C. (2007). Distinct domains of complexin I differentially regulate neurotransmitter release. Nat. Struct. Mol. Biol. 14, 949-958 https://doi.org/10.1038/nsmb1292
  62. Yamada, M., Saisu, H., Ishizuka, T., Takahashi, H., and Abe, T. (1999). Immunohistochemical distribution of the two isoforms of synaphin/complexin involved in neurotransmitter release: localization at the distinct central nervous system regions and synaptic types. Neuroscience 93, 7-18 https://doi.org/10.1016/S0306-4522(99)00104-9
  63. Yamauchi, Y., Qin, L.H., Nishihara, M., Sawada, K., Kato, K., and Inoue, S. (2005). Vulnerability of synaptic plasticity in the complexin II knockout mouse to maternal deprivation stress. Brain Res. 1056, 59-67 https://doi.org/10.1016/j.brainres.2005.07.015
  64. Yi, J.H., Hoover, R., McIntosh, T.K., and Hazell, A.S. (2006). Early, transient increase in complexin I and complexin II in the cerebral cortex following traumatic brain injury is attenuated by N-acetylcysteine. J. Neurotrauma 23, 86-96 https://doi.org/10.1089/neu.2006.23.86
  65. Zabel, C. and Klose, J. (2004). Influence of Huntington's disease on the human and mouse proteome. Int. Rev. Neurobiol. 61, 241-283 https://doi.org/10.1016/S0074-7742(04)61010-5
  66. Zabel, C., Sagi, D., Kaindl, A.M., Steireif, N., Klare, Y., Mao, L., Peters, H., Wacker, M.A., Kleene, R., and Klose, J. (2006). Comparative proteomics in neurodegenerative and nonneurodegenerative diseases suggest nodal point proteins in regulatory networking. J. Proteome Res. 5, 1948-1958 https://doi.org/10.1021/pr0601077
  67. Zink, M., Rapp, S., Gebicke-Haerter, P.J., Henn, F.A., and Thome, J. (2005). Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus. Psychopharmacology 181, 560-565 https://doi.org/10.1007/s00213-005-0017-4
  68. Zink, M., Vollmayr, B., Gebicke-Haerter, P.J., Henn, F.A., and Thome, J. (2007). Reduced expression of complexins I and II in rats bred for learned helplessness. Brain Res. 1144, 202-208 https://doi.org/10.1016/j.brainres.2007.01.066